CBIO News and Press, Catalyst Biosciences Inc.

The combined company will operate as “Gyre Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “GYRE” effective Tuesday, October 31, 2023 SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq: CBIO) (“...

Catalyst Biosciences Inc. (CBIO) is expected to report $-0.05 for Q3 2023

NEW YORK, NY / ACCESSWIRE / March 1, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Broadmark Realty Capital Inc. (NYS...

A San Francisco-based %Biotech company is off to the races on Tuesday morning after the company announced it has signed an asset purchase agreement with GCBiopharma (GCBP) pursuant to which GCBP acquired the Company’s legacy rare %BleedingDisorders programs including marzeptacog al...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Supavadee butradee / Shutterstock.com AdaptHealth (NASDAQ: AHCO ) stock is falling on Tuesday following the release of the company’s earnings report for the fourth quarter of 2022. The bad news for ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Intelligent Living (NASDAQ: ILAG ) stock is heading higher on Tuesday after the company announced plans to develop home security devices . According to a recent press release from the company...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock.com Catalyst Biosciences (NASDAQ: CBIO ) stock is rocketing higher on Tuesday after the company announced an asset purchase agreement with GC Biopharma . That agreement has Catalyst Bioscie...

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Catalyst Biosciences Inc. (NASDAQ: CBIO) (“Catalyst” or “the Company”) today provided two corporate updates. In connection with the Company’s previously announced asset purchase agreement wit...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time to start the day with a look at the biggest pre-market stock movers traders need to know about on Monday! Moving stocks this morning are earnings reports, clinical tria...

South Korea's GC Biopharma is acquiring three programs related to orphan blood disorders from Catalyst Biosciences ( NASDAQ: CBIO ). The agreement will bring to GC Biopharma programs, including Marzeptacog alfa (MarzAA), an engineered factor VIIa which is ready for phase 3 d...